Protein sialylation by sialyltransferase involves radiation resistance

Molecular Cancer Research

Volumn 6, Issue 8, 2008, Pages 1316-1325

  Lee, Minyoung ^a   Lee, Hae June ^a   Bae, Sangwoo ^a   Lee, Yun Sil ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE ALPHA(2,6) SIALYLTRANSFERASE; BETA1 INTEGRIN; CASPASE 3; NEURAMINIDASE 2; NEURAMINIDASE 3; SIALYLTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BETA D GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; GLYCOPROTEIN; SIALIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL SURVIVAL; CLONE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME STABILITY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SIALYLATION; RADIATION EXPOSURE; SIALYLATION; ANIMAL; C57BL MOUSE; CELL LINE; CELL MEMBRANE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RADIATION DOSE; SOLUBILITY; THERMODYNAMICS;

ANIMALS; ANTIGENS, CD29; CELL LINE; CELL MEMBRANE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED C57BL; RADIATION TOLERANCE; RADIATION, IONIZING; SIALIC ACIDS; SIALYLTRANSFERASES; SOLUBILITY; THERMODYNAMICS;

EID: 52449128933     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-2209     Document Type: Article

References (65)

1. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130.
2. Schauer R. Achievements and challenges of sialic acid research. Glycoconj J 2000;17:485-99.
3. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J 1997;11:248-55.
4. Kelm S, Schauer R. Sialic acids in molecular and cellular interactions. Int Rev Cytol 1997;175:137-240.
5. Dall'Olio F, Malagolini N, di Stefano G, Minni F, Marrano D, Serafini-Cessi F. Increased CMP-NeuAc:Gal β1,4GlcNAc-R α2,6 sialyltransferase activity in human colorectal cancer tissues. Int J Cancer 1989;44:434-9.
6. Gessner P, Riedl S, Quentmaier A, Kemmner W. Enhanced activity of CMP-neuAc: Gal β1-4GlcNAc:α2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett 1993;75:143-9.
7. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001;83:727-37.
8. Takashima S, Tsuji S, Tsujimoto M. Characterization of the second type of human β-galactoside α2,6-sialyltransferase (ST6Gal II), which sialylates Galβ1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J Biol Chem 2002;277:45719-28.
9. Krzewinski-Recchi MA, Julien S, Juliant S, et al. Identification and functional expression of a second human β-galactoside α2,6- sialyltransferase, ST6Gal II. Eur J Biochem 2003;270:950-61.
10. Kemmner W, Kruck D, Schlag P. Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors. Clin Exp Metastasis 1994;12:245-54.
11. Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F. α2,6 sialylation of N-acetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth. Int J Cancer 1991;47:291-7.
12. Martin LT, Marth JD, Varki A, Varki NM. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. J Biol Chem 2002;277:32930-8.
13. Wang X, Vertino A, Eddy RL, et al. Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem 1993;268:4355-61.
14. Kalcheva I, Elliott RW, Dalziel M, Lau JT. The gene encoding β-galactoside α2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome 1997;8:619-20.
15. 2-terminal signal anchor. J Biol Chem 1987;262:17735-43.
16. Paulson JC, Weinstein J, Schauer A. Tissue-specific expression of sialyltransferases. J Biol Chem 1989;264:10931-4.
17. Weinstein J, de Souza-e-Silva U, Paulson JC. Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal β1 to 3(4)GlcNAc α2 to 3 sialyltransferase and a Gal β1 to 4GlcNAc α2 to 6 sialyltransferase from rat liver. J Biol Chem 1982;257:13845-53.
18. Wuensch SA, Huang RY, Ewing J, Liang X, Lau JT. Murine B cell differentiation is accompanied by programmed expression of multiple novel β-galactoside α2,6-sialyltransferase mRNA forms. Glycobiology 2000;10:67-75.
19. Dalziel M, Huang RY, Dall'Olio F, Morris JR, Taylor-Papadimitriou J, Lau JT. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation. Glycobiology 2001;11:407-12.
20. Dall'Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J 2001;18:841-50.
21. Yamamoto H, Oviedo A, Sweeley C, Saito T, Moskal JR. α2,6- sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Cancer Res 2001;61:6822-9.
22. Yamamoto H, Kaneko Y, Rebbaa A, Bremer EG, Moskal JR. α2,6-Sialyltransferase gene transfection into a human glioma cell line (U373 MG) results in decreased invasivity. J Neurochem 1997;68:2566-76.
23. Lee WJ, Majumder ZR, Jeoung DI, et al. Organ-specific gene expressions in C57BL/6 mice after exposure to low-dose radiation. Radiat Res 2006;165:562-9.
24. Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem 2002;277:32830-6.
25. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of β1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 2005;65:4645-52.
26. Dall'Olio F, Chiricolo M, Lau JT. Differential expression of the hepatic transcript of β-galactoside α2,6-sialyltransferase in human colon cancer cell lines. Int J Cancer 1999;81:243-7.
27. Hidari KI, Horie N, Murata T, et al. Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli. Glycoconj J 2005;22:1-11.
28. Cerna A, Janega P, Martanovic P, Lisy M, Babal P. Changes in sialic acid expression in the lung during intrauterine development of the human fetus. Acta Histochem 2002;104:339-42.
29. Sierra C, Guevara J, Lascurain R, et al. Sialylation is modulated through maturation in hemocytes from Macrobrachium rosenbergii. Comp Biochem Physiol C Toxicol Pharmacol 2001;130:179-89.
30. Martin-Rendon E, Blake DJ. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Trends Pharmacol Sci 2003;24:178-83.
31. Aebi M, Hennet T. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol 2001;11:136-41.
32. Blake DJ, Esapa CT, Martin-Rendon E, McIlhinney RA. Glycosylation defects and muscular dystrophy. Adv Exp Med Biol 2005;564:97-8.
33. Guevara J, Espinosa B, Zenteno E, et al. Altered glycosylation pattern of proteins in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:905-14.
34. Rudd PM, Merry AH, Wormald MR, Dwek RA. Glycosylation and prion protein. Curr Opin Struct Biol 2002;12:578-86.
35. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.
36. Kitazume S, Tachida Y, Oka R, et al. Characterization of α2,6-sialyltransferase cleavage by Alzheimer's β-secretase (BACE1). J Biol Chem 2003;278:14865-71.
37. Sugimoto I, Futakawa S, Oka R, et al. β-Galactoside α2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for α2,6-sialylation. J Biol Chem 2007;282:34896-903.
38. Snider MD, Rogers OC. Intracellular movement of cell surface receptors after endocytosis: resialylation of asialo-transferrin receptor in human erythroleukemia cells. J Cell Biol 1985;100:826-34.
39. Scherthan H, Abend M, Muller K, et al. Radiation-induced late effects in two affected individuals of the Lilo radiation accident. Radiat Res 2007;167:615-23.
40. Zheng M, Fang H, Hakomori S. Functional role of N-glycosylation in α5β1 integrin receptor. De-N-glycosylation induces dissociation or altered association of α5 and β1 subunits and concomitant loss of fibronectin binding activity. J Biol Chem 1994;269:12325-31.
41. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995;130:383-92.
42. Clement M, Rocher J, Loirand G, Le Pendu J. Expression of sialyl-Tn epitopes on β1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. J Cell Sci 2004;117:5059-69.
43. Julien S, Lagadec C, Krzewinski-Recchi MA, Courtand G, Le Bourhis X, Delannoy P. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res Treat 2005;90:77-84.
44. Pochec E, Litynska A, Amoresano A, Casbarra A. Glycosylation profile of integrin α3β1 changes with melanoma progression. Biochim Biophys Acta 2003;1643:113-23.
45. Sudou A, Ozawa M, Muramatsu T. Lewis X structure increases cell substratum adhesion in L cells. J Biochem (Tokyo) 1995;117:271-5.
46. Wang X, Sun P, Al-Qamari A, Tai T, Kawashima I, Paller AS. Carbohydrate-carbohydrate binding of ganglioside to integrin α(5) modulates α(5)β(1) function. J Biol Chem 2001;276:8436-44.
47. Akiyama SK, Yamada SS, Yamada KM. Analysis of the role of glycosylation of the human fibronectin receptor. J Biol Chem 1989;264:18011-8.
48. Chiricolo M, Malagolini N, Bonfiglioli S, Dall'Olio F. Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948. Glycobiology 2006;16:146-54.
49. Collard JG, Schijven JF, Bikker A, La Riviere G, Bolscher JG, Roos E. Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas. Cancer Res 1986;46:3521-7.
50. Le Marer N, Laudet V, Svensson EC, et al. The c-Ha-ras oncogene induces increased expression of β-galactoside α-2,6-sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiology 1992;2:49-56.
51. Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 2001;1536:148-60.
52. Dall'Olio F, Malagolini N, Serafini-Cessi F. Enhanced CMP-NeuAc:Gal β1,4GlcNAc-R α2,6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines. Int J Cancer 1992;50:325-30.
53. Bresalier RS, Ho SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996;110:1354-67.
54. Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 1998;58:4066-70.
55. Wang PH, Li YF, Juang CM, et al. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol Oncol 2001;83:121-7.
56. Fukushima K, Hara-Kuge S, Seko A, Ikehara Y, Yamashita K. Elevation of α2→6 sialyltransferase and α1→2 fucosyltransferase activities in human choriocarcinoma. Cancer Res 1998;58:4301-6.
57. Biswas S, Guix M, Rinehart C, et al. Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 2007;117:1305-13.
58. Tanaka IB III, Tanaka S, Ichinohe K, et al. Cause of death and neoplasia in mice continuously exposed to very lowdose rates of gamma rays. Radiat Res 2007;167:417-37.
59. Lee YJ, Lee DH, Cho CK, et al. HSP25 inhibits protein kinase Cδ-mediated cell death through direct interaction. J Biol Chem 2005;280:18108-19.
60. Park SH, Cho HN, Lee SJ, et al. Hsp25-induced radioresistance is associated with reduction of death by apoptosis: involvement of Bcl2 and the cell cycle. Radiat Res 2000;154:421-8.
61. Park SH, Lee SJ, Chung HY, et al. Inducible heat-shock protein 70 is involved in the radioadaptive response. Radiat Res 2000;153:318-26.
62. Lee HJ, Lee YJ, Kwon HC, et al. Radioprotective effect of heat shock protein 25 on submandibular glands of rats. Am J Pathol 2006;169:1601-11.
63. Lin S, Kemmner W, Grigull S, Schlag PM. Cell surface α2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res 2002;276:101-10.
64. Batisse C, Marquet J, Greffard A, Fleury-Feith J, Jaurand MC, Pilatte Y. Lectin-based three-color flow cytometric approach for studying cell surface glycosylation changes that occur during apoptosis. Cytometry A 2004;62:81-8.
65. Wang L, Liang Y, Li Z, et al. Increase in β1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin β1 stability in human hepatocellular carcinoma cell line SMMC-7721. J Cell Biochem 2007;100:230-41.